Published in:
01-02-2010
Functional Assessment of HDL: Moving Beyond Static Measures for Risk Assessment
Author:
Robert S. Rosenson
Published in:
Cardiovascular Drugs and Therapy
|
Issue 1/2010
Login to get access
Excerpt
Residual cardiovascular risk associated with low levels of HDL was a major theme at the American Heart Association’s 2009 Scientific Sessions. The presentations on HDL biology encompassed a broad spectrum of investigations that ranged from population-based studies, anti-atherothrombotic mechanisms of HDL particles, and therapeutic approaches to raising HDL cholesterol levels. This meeting highlight reviews some of the most important presentations that serve to enhance our knowledge in areas that extend beyond measurement of HDL cholesterol or apolipoprotein A-I concentration to precise mechanisms that elucidate functional aspects of HDL particles. …